{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:24:12Z","timestamp":1764174252688,"version":"3.40.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.dld.2016.05.013","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T23:48:43Z","timestamp":1464133723000},"page":"927-933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Autoimmunity and lymphoproliferation markers in na\u00efve HCV-RNA positive patients without clinical evidences of autoimmune\/lymphoproliferative disorders"],"prefix":"10.1016","volume":"48","author":[{"given":"Francesca","family":"Gulli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8328-2570","authenticated-orcid":false,"given":"Umberto","family":"Basile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6800-9149","authenticated-orcid":false,"given":"Laura","family":"Gragnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Fognani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Napodano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Colacicco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Miele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"De Matthaeis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Cattani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Linda","family":"Zignego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Ludovico","family":"Rapaccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2016.05.013_bib0140","doi-asserted-by":"crossref","first-page":"980942","DOI":"10.1155\/2012\/980942","article-title":"HCV and lymphoproliferation","volume":"2012","author":"Zignego","year":"2012","journal-title":"Clinical and Developmental Immunology"},{"issue":"S5","key":"10.1016\/j.dld.2016.05.013_bib0145","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.dld.2014.10.005","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection","volume":"46","author":"Cacoub","year":"2014","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2016.05.013_bib0150","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1586\/1744666X.2015.997214","article-title":"Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection","volume":"11","author":"Zignego","year":"2015","journal-title":"Expert Review of Clinical Immunology"},{"key":"10.1016\/j.dld.2016.05.013_bib0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jcp.55.1.4","article-title":"Cryoglobulins","volume":"55","author":"Ferri","year":"2002","journal-title":"Journal of Clinical Pathology"},{"key":"10.1016\/j.dld.2016.05.013_bib0160","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0002-9343(74)90852-3","article-title":"Biologic and clinical significance of cryoglobulins. A report of 86 cases","volume":"57","author":"Brouet","year":"1974","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.dld.2016.05.013_bib0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12250-014-3414-1","article-title":"Role of hepatitis C virus in B cell lymphoproliferations","volume":"29","author":"Tucci","year":"2014","journal-title":"Virologica Sinica"},{"key":"10.1016\/j.dld.2016.05.013_bib0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.dld.2014.09.010","article-title":"Anti-nuclear antibody detection in cryoprecipitates: distinctive patterns in hepatitis C virus-infected patients","volume":"47","author":"Basile","year":"2015","journal-title":"Digestive and Liver Disease"},{"key":"10.1016\/j.dld.2016.05.013_bib0175","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/gut.45.3.435","article-title":"Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case\u2013control study of the Dionysos cohort see comments","volume":"45","author":"Lenzi","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.dld.2016.05.013_bib0180","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.amjmed.2009.03.040","article-title":"Cryofibrinogenemia: new insights into clinical and pathogenic features","volume":"122","author":"Saadoun","year":"2009","journal-title":"American Journal of Medicine"},{"key":"10.1016\/j.dld.2016.05.013_bib0185","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.6004\/jnccn.2011.0095","article-title":"Multiple myeloma","volume":"9","author":"Anderson","year":"2011","journal-title":"Journal of the National Comprehensive Cancer Network"},{"key":"10.1016\/j.dld.2016.05.013_bib0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.dld.2016.05.013_bib0195","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/leu.2013.293","article-title":"International Myeloma Working Group recommendations for global myeloma care","volume":"28","author":"Ludwig","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.dld.2016.05.013_bib0200","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.dld.2016.05.013_bib0205","doi-asserted-by":"crossref","DOI":"10.1111\/liv.12829","article-title":"Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment","author":"Basile","year":"2015","journal-title":"Liver International"},{"key":"10.1016\/j.dld.2016.05.013_bib0210","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5858\/1999-123-0119-EOC","article-title":"Evaluation of cryoglobulins","volume":"123","author":"Kallemuchikkal","year":"1999","journal-title":"Archives of Pathology and Laboratory Medicine"},{"key":"10.1016\/j.dld.2016.05.013_bib0215","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.revmed.2014.09.007","article-title":"Cryofibrinogenemia: a single-center study at the University Hospital of Toulouse, France","volume":"36","author":"Michaud","year":"2015","journal-title":"Revue de Medecine Interne"},{"key":"10.1016\/j.dld.2016.05.013_bib0220","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/ard.2009.127100","article-title":"ANA screening: an old test with new recommendations","volume":"69","author":"Meroni","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.dld.2016.05.013_bib0225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/annrheumdis-2013-203863","article-title":"International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies","volume":"73","author":"Agmon-Levin","year":"2014","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.dld.2016.05.013_bib0230","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis \u2013 update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.dld.2016.05.013_bib0235","doi-asserted-by":"crossref","first-page":"783063","DOI":"10.1155\/2015\/783063","article-title":"Comparison between the traditional a rapid screening test for cryoimmunoglobulins detection","volume":"2015","author":"Romitelli","year":"2015","journal-title":"BioMed Research International"},{"key":"10.1016\/j.dld.2016.05.013_bib0240","unstructured":"Recommendations for testing, managing, and treating hepatitis C, http:\/\/www.hcvguidelines.org; 2014 [accessed 24.04.14]."},{"key":"10.1016\/j.dld.2016.05.013_bib0245","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.mayocp.2012.07.012","article-title":"Polyclonal immunoglobulin free light chain and chronic inflammation","volume":"87","author":"Redegeld","year":"2012","journal-title":"Mayo Clinic Proceedings"},{"key":"10.1016\/j.dld.2016.05.013_bib0250","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/gut.45.3.435","article-title":"Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case\u2013control study of the Dionysos cohort","volume":"45","author":"Lenzi","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.dld.2016.05.013_bib0255","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510260305","article-title":"Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile","volume":"26","author":"Cassani","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.dld.2016.05.013_bib0260","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1365-2249.2003.02229.x","article-title":"Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection","volume":"133","author":"Gregorio","year":"2003","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.dld.2016.05.013_bib0265","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/00365529609009156","article-title":"Induction of antinuclear antibody after interferon therapy in patients with type-C chronic hepatitis: its relation to the efficacy of therapy","volume":"31","author":"Noda","year":"1996","journal-title":"Scandinavian Journal of Gastroenterology"},{"key":"10.1016\/j.dld.2016.05.013_bib0270","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/0016-5085(94)90564-9","article-title":"Hepatitis C virus and autoimmunity: fortuitous association or reality?","volume":"107","author":"Lunel","year":"1994","journal-title":"Gastroenterology"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865816304303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865816304303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T09:17:12Z","timestamp":1656580632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865816304303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S1590865816304303"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2016.05.013","relation":{},"ISSN":["1590-8658"],"issn-type":[{"type":"print","value":"1590-8658"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmunity and lymphoproliferation markers in na\u00efve HCV-RNA positive patients without clinical evidences of autoimmune\/lymphoproliferative disorders","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2016.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}